French guidelines for diagnostic criteria for nonviable pregnancy early in the first trimester and for management of threatened miscarriage and nonviable pregnancy (except uterine evacuation);Recommandations françaises pour les critères diagnostiques d'arrêt de grossesse au premier trimestre et stratégie de prise en charge des patientes présentant une menace de fausse couche ou une grossesse arrêtée (hors évacuation utérine)

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 43, Issue 10, 2014, Pages 776-793

  Lavoue V ^a,b   Huchon, C ^c   Deffieux, X ^d,e,f   Voltzenlogel, M C ^a,b   Vandenbroucke, L ^a,b   Leveque J ^a,b  

^a SERVICE DE RHUMATOLOGIE   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^d HÔPITAL ANTOINE BÉCLÈRE   (France)

^e Groupe de Recherche Clinique en Neuro urologie   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Human chorionicgonadotrophin; Miscarriage; Progesterone; Sonography; Spontaneousabortion

Indexed keywords

CHORIONIC GONADOTROPIN; PROGESTERONE;

ARTICLE; CLINICAL ASSESSMENT; CROWN RUMP LENGTH; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FIRST TRIMESTER MISCARRIAGE; FIRST TRIMESTER NONVIABLE PREGNANCY; FIRST TRIMESTER PREGNANCY; FRANCE; GESTATIONAL SAC; HUMAN; IMMINENT ABORTION; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY DISORDER; PROGESTERONE BLOOD LEVEL; TRANSVAGINAL ECHOGRAPHY; ABORTION, SPONTANEOUS; BLOOD; DIAGNOSTIC IMAGING; FEMALE; FETUS ECHOGRAPHY; PREGNANCY COMPLICATIONS; STANDARDS;

ABORTION, SPONTANEOUS; CHORIONIC GONADOTROPIN; FEMALE; FRANCE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PROGESTERONE; ULTRASONOGRAPHY, PRENATAL;

EID: 84920001140     PISSN: 03682315     EISSN: 17730430     Source Type: Journal    
DOI: 10.1016/j.jgyn.2014.09.014     Document Type: Article

References (75)

1. Wieringa-de Waard M, et al. Threatened miscarriage in gene-ral practice: diagnostic value of history taking and physicalexamination. Br J Gen Pract 2002; 52: 825-9.
2. Doubilet PM, et al. Diagnostic criteria for nonviable pre-gnancy early in the first trimester. N Engl J Med 2013; 369: 1443-51.
3. Timor-Tritsch IE, Farine D, Rosen MG. A close look at earlyembryonic development with the high-frequency transvaginaltransducer. Am J Obstet Gynecol 1988; 159: 676-81.
4. Bree RL, et al. Transvaginal sonography in the evaluation ofnormal early pregnancy: correlation with HCG level. AJR Am JRoentgenol 1989; 153: 75-9.
5. Warren WB, et al. Dating the early pregnancy by sequentialappearance of embryonic structures. Am J Obstet Gynecol1989; 161: 747-53.
6. Coulam CB, Britten S, Soenksen DM. Early (34-56 days from lastmenstrual period) ultrasonographic measurements in normalpregnancies. Hum Reprod 1996; 11: 1771-4.
7. Jauniaux E, et al. Development of the secondary human yolksac: correlation of sonographic and anatomical features. HumReprod 1991; 6: 1160-6.
8. Britten S, et al. Very early (24-56 days from last menstrual per-iod) embryonic heart rate in normal pregnancies. Hum Reprod1994; 9: 2424-6.
9. Robinson HP. Sonar measurement of fetal crown-rump lengthas means of assessing maturity in first trimester of pregnancy. Br Med J 1973; 4: 28-31.
10. Robinson HP, Fleming JE. A critical evaluation of sonar"crown-rump length" measurements. Br J Obstet Gynaecol1975; 82: 702-10.
11. Hadlock FP, et al. Fetal crown-rump length: reevaluation ofrelation to menstrual age (5-18 weeks) with high-resolutionreal-time US. Radiology 1992; 182: 501-5.
12. Daya S. Accuracy of gestational age estimation by means offetal crown-rump length measurement. Am J Obstet Gynecol1993; 168: 903-8.
13. Wisser J, Dirschedl P, Krone S. Estimation of gestational age bytransvaginal sonographic measurement of greatest embryoniclength in dated human embryos. Ultrasound Obstet Gynecol1994; 4: 457-62.
14. Kustermann A, et al. Transvaginal sonography for fetalmeasurement in early pregnancy. Br J Obstet Gynaecol1992; 99: 38-42.
15. Bottomley C, Bourne T. Dating and growth in the first trimester. Best Pract Res Clin Obstet Gynaecol 2009; 23: 439-52.
16. Pexsters A, et al. New crown-rump length curve based onover 3500 pregnancies. Ultrasound Obstet Gynecol 2010; 35: 650-5.
17. Hellman LM, et al. Growth and development of the human fetusprior to the twentieth week of gestation. Am J Obstet Gynecol1969; 103: 789-800.
18. Goldstein I, et al. Evaluation of normal gestational sacgrowth: appearance of embryonic heartbeat and embryo bodymovements using the transvaginal technique. Obstet Gynecol1991; 77: 885-8.
19. Oh JS, Wright G, Coulam CB. Gestational sac diameter in veryearly pregnancy as a predictor of fetal outcome. UltrasoundObstet Gynecol 2002; 20: 267-9.
20. Abdallah Y, et al. Limitations of current definitions of miscar-riage using mean gestational sac diameter and crown-rumplength measurements: a multicenter observational study. Ultrasound Obstet Gynecol 2011; 38: 497-502.
21. Bottomley C, et al. Functional linear discriminant analysis: a new longitudinal approach to the assessment of embryonicgrowth. Hum Reprod 2009; 24: 278-83.
22. Choong S, et al. Ultrasound prediction of risk of spontaneousmiscarriage in live embryos from assisted conceptions. Ultra-sound Obstet Gynecol 2003; 22: 571-7.
23. Guha S, et al. External validation of models and simple scoringsystems to predict miscarriage in intrauterine pregnancies ofuncertain viability. Hum Reprod 2013; 28: 2905-11.
24. Oates J, et al. A prediction model for viability at the end of thefirst trimester after a single early pregnancy evaluation. AustN Z J Obstet Gynaecol 2013; 53: 51-7.
25. Pexsters A, et al. Clinical implications of intra- and interobser-ver reproducibility of transvaginal sonographic measurement ofgestational sac and crown-rump length at 6-9 weeks' gestation. Ultrasound Obstet Gynecol 2011; 38: 510-5.
26. Verburg BO, et al. Intra- and interobserver reproducibi-lity study of early fetal growth parameters. Prenat Diagn2008; 28: 323-31.
27. Ferrazzi E, et al. Miscarriage diagnosis and gestational ageestimation in the early first trimester of pregnancy: trans-abdominal versus transvaginal sonography. Ultrasound ObstetGynecol 1993; 3: 36-41.
28. Jain KA, Hamper UM, Sanders RC. Comparison of transva-ginal and transabdominal sonography in the detection ofearly pregnancy and its complications. AJR Am J Roentgenol1988; 151: 1139-43.
29. Pennell RG, et al. Prospective comparison of vaginal and abdo-minal sonography in normal early pregnancy. J Ultrasound Med1991; 10: 63-7.
30. Cacciatore B, Stenman UH, Ylostalo P. Comparison of abdominaland vaginal sonography in suspected ectopic pregnancy. ObstetGynecol 1989; 73: 770-4.
31. Bradley WG, Fiske CE, Filly RA. The double sac sign of earlyintrauterine pregnancy: use in exclusion of ectopic pregnancy. Radiology 1982; 143: 223-6.
32. Yeh HC, et al. Intradecidual sign: a US criterion of early intrau-terine pregnancy. Radiology 1986; 161: 463-7.
33. Laing FC, et al. Intradecidual sign: is it effective in diagno-sis of an early intrauterine pregnancy? Radiology 1997; 204: 655-60.
34. Chiang G, et al. The intradecidual sign: is it reliable for diag-nosis of early intrauterine pregnancy? AJR Am J Roentgenol2004; 183: 725-31.
35. Doubilet PM, Benson CB. Double sac sign and intradecidual signin early pregnancy: interobserver reliability and frequency ofoccurrence. J Ultrasound Med 2013; 32: 1207-14.
36. Mueller CE. Intrauterine pseudogestational sac in ectopic pre-gnancy. J Clin Ultrasound 1979; 7: 133-6.
37. Crochet JR, Bastian LA, Chireau MV. Does this woman have anectopic pregnancy? The rational clinical examination systema-tic review. JAMA 2013; 309: 1722-9.
38. Fernandez H, Gervaise A. Ectopic pregnancies after infertilitytreatment: modern diagnosis and therapeutic strategy. HumReprod Update 2004; 10: 503-13.
39. Jeve Y, et al. Accuracy of first trimester ultrasound in thediagnosis of early embryonic demise: a systematic review. Ultrasound Obstet Gynecol 2011; 38: 489-96.
40. Verhaegen J, et al. Accuracy of single progesterone test to pre-dict early pregnancy outcome in women with pain or bleeding: meta-analysis of cohort studies. BMJ 2012; 345: e6077.
41. Sheiner E, Abramowicz JS. A symposium on obstetrical ultra-sound: is all this safe for the fetus? Clin Obstet Gynecol2012; 55: 188-98.
42. Condous G, et al. Prediction of ectopic pregnancy in womenwith a pregnancy of unknown location. Ultrasound ObstetGynecol 2007; 29: 680-7.
43. Kirk E, et al. Rationalizing the follow-up of pre-gnancies of unknown location. Hum Reprod 2007; 22: 1744-50.
44. Mazouz S, Lee JK, Fernandez H. Evaluation of a urinary testas a diagnostic tool of a nonprogressive pregnancy. Fertil Steril2011; 95: 783-6.
45. Connolly A, et al. Reevaluation of discriminatory and thresholdlevels for serum beta-hCG in early pregnancy. Obstet Gynecol2013; 121: 65-70.
46. Pittaway DE, Reish RL, Wentz AC. Doubling times of humanchorionic gonadotropin increase in early viable intrauterinepregnancies. Am J Obstet Gynecol 1985; 152: 299-302.
47. Barnhart KT, et al. Symptomatic patients with an early viableintrauterine pregnancy: HCG curves redefined. Obstet Gynecol2004; 104: 50-5.
48. Seeber BE, et al. Application of redefined human chorionicgonadotropin curves for the diagnosis of women at risk forectopic pregnancy. Fertil Steril 2006; 86: 454-9.
49. Morse CB, et al. Performance of human chorionic gonadotropincurves in women at risk for ectopic pregnancy: exceptions tothe rules. Fertil Steril 2012; 97: 101-6 [e2].
50. Horne AW, McBride R, Denison FC. Normally rising hCG doesnot predict live birth in women presenting with pain and blee-ding in early pregnancy. Eur J Obstet Gynecol Reprod Biol2011; 156: 120-1.
51. Silva C, et al. Human chorionic gonadotropin profile forwomen with ectopic pregnancy. Obstet Gynecol 2006; 107: 605-10.
52. Massart C, et al. Application of a rapid serum beta-hCG assay inthe early diagnosis of the ectopic pregnancies (author's transl). J Gynecol Obstet Biol Reprod (Paris) 1981; 10: 675-81.
53. Bottomley C, et al. Accurate prediction of pregnancy via-bility by means of a simple scoring system. Hum Reprod2013; 28: 68-76.
54. Lautmann K, et al. Clinical use of a model to predict the viabi-lity of early intrauterine pregnancies when no embryo is visibleon ultrasound. Hum Reprod 2011; 26: 2957-63.
55. Mantoni M, Pedersen JF. Fetal growth delay in threatenedabortion: an ultrasound study. Br J Obstet Gynaecol 1982; 89: 525-7.
56. Reljic M. The significance of crown-rump length measurementfor predicting adverse pregnancy outcome of threatened abor-tion. Ultrasound Obstet Gynecol 2001; 17: 510-2.
57. Mukri F, et al. Evidence of early first trimester growth restric-tion in pregnancies that subsequently end in miscarriage. BJOG2008; 115: 1273-8.
58. Johns J, Hyett J, Jauniaux E. Obstetric outcome after threate-ned miscarriage with and without a hematoma on ultrasound. Obstet Gynecol 2003; 102: 483-7.
59. Cashner KA, Christopher CR, Dysert GA. Spontaneous fetal lossafter demonstration of a live fetus in the first trimester. ObstetGynecol 1987; 70: 827-30.
60. Siddiqi TA, et al. Rate of spontaneous abortion after first tri-mester sonographic demonstration of fetal cardiac activity. AmJ Perinatol 1988; 5: 1-4.
61. Hill LM, et al. Fetal loss rate after ultrasonically documentedcardiac activity between 6 and 14 weeks, menstrual age. J ClinUltrasound 1991; 19: 221-3.
62. Makrydimas G, et al. Fetal loss following ultrasound diagnosisof a live fetus at 6-10 weeks of gestation. Ultrasound ObstetGynecol 2003; 22: 368-72.
63. Aleman A, et al. Bed rest during pregnancy for preventing mis-carriage. Cochrane Database Syst Rev 2005: CD003576.
64. Rumbold A, et al. Vitamin supplementation for preventing mis-carriage. Cochrane Database Syst Rev 2011: CD004073.
65. Haas DM, Ramsey PS. Progestogen for preventing miscarriage. Cochrane Database Syst Rev 2013; 10: CD003511.
66. Gerhard I, et al. Double-blind controlled trial of progesteronesubstitution in threatened abortion. Biol Res Pregnancy Perina-tol 1987; 8: 26-34.
67. Reijnders FJ, et al. Endocrine effects of 17 alpha-hydroxyprogesterone caproate during early pregnancy: adouble-blind clinical trial. Br J Obstet Gynaecol 1988; 95: 462-8.
68. Tognoni G, et al. Progestagens in threatened abortion. Lancet1980; 2: 1242-3.
69. Gallot V, Nedellec S, Capmas P, Legendre G, Lejeune-SaadaV, Subtil D, et al. Fausses couches précoces « à répétition »: bilan et prise en charge. J Gynecol Obstet Biol Reprod 2014, http://dx.doi.org/10.1016/j.jgyn.2014.09.014.
70. Morley LC, Simpson N, Tang T. Human chorionic gonadotrophin(hCG) for preventing miscarriage. Cochrane Database Syst Rev2013; 1: CD008611.
71. Li L, et al. Chinese herbal medicines for threatened miscar-riage. Cochrane Database Syst Rev 2012; 5: CD008510.
72. Van den Berg MM, et al. Genetics of early miscarriage. BiochimBiophys Acta 2012; 1822: 1951-9.
73. Lathi RB, et al. Reliability of 46, XX results on miscarriage spe-cimens: a review of 1222 first trimester miscarriage specimens. Fertil Steril 2014; 101: 178-82.
74. Love ER, et al. Effect of interpregnancy interval on outcomes ofpregnancy after miscarriage: retrospective analysis of hospitalepisode statistics in Scotland. BMJ 2010; 341: c3967.
75. El Behery MM, et al. Reproductive performance in the nextpregnancy for nulliparous women with history of first trimesterspontaneous abortion. Arch Gynecol Obstet 2013; 288: 939-44.